Use of the likelihood reduction factor in a path analysis framework to quantify surrogacy in clinical trials

DOI10.1002/sim.9188zbMATH Open1546.62104MaRDI QIDQ6628182

Yang Song, Joseph M. Massaro, Howard J. Cabral, Katherine Bloore, Michael LaValley

Publication date: 29 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

clinical trialssurrogate endpointspath analysis

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• The method of path coefficients.
• Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints
• Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
• Quantifying the Effect of the Surrogate Marker by Information Gain

This page was built for publication: Use of the likelihood reduction factor in a path analysis framework to quantify surrogacy in clinical trials